Modulation of DBS-induced cortical responses and movement by the directionality and magnitude of current administered

Rachel K. Spooner,Baccara J. Hizli,Bahne H. Bahners,Alfons Schnitzler,Esther Florin

DOI: https://doi.org/10.1038/s41531-024-00663-9

2024-03-08

Abstract:Abstract Subthalamic deep brain stimulation (STN-DBS) is an effective therapy for alleviating motor symptoms in people with Parkinson’s disease (PwP), although some may not receive optimal clinical benefits. One potential mechanism of STN-DBS involves antidromic activation of the hyperdirect pathway (HDP), thus suppressing cortical beta synchrony to improve motor function, albeit the precise mechanisms underlying optimal DBS parameters are not well understood. To address this, 18 PwP with STN-DBS completed a 2 Hz monopolar stimulation of the left STN during MEG. MEG data were imaged in the time-frequency domain using minimum norm estimation. Peak vertex time series data were extracted to interrogate the directional specificity and magnitude of DBS current on evoked and induced cortical responses and accelerometer metrics of finger tapping using linear mixed-effects models and mediation analyses. We observed increases in evoked responses (HDP ~ 3–10 ms) and synchronization of beta oscillatory power (14–30 Hz, 10–100 ms) following DBS pulse onset in the primary sensorimotor cortex (SM1), supplementary motor area (SMA) and middle frontal gyrus (MFG) ipsilateral to the site of stimulation. DBS parameters significantly modulated neural and behavioral outcomes, with clinically effective contacts eliciting significant increases in medium-latency evoked responses, reductions in induced SM1 beta power, and better movement profiles compared to suboptimal contacts, often regardless of the magnitude of current applied. Finally, HDP-related improvements in motor function were mediated by the degree of SM1 beta suppression in a setting-dependent manner. Together, these data suggest that DBS-evoked brain-behavior dynamics are influenced by the level of beta power in key hubs of the basal ganglia-cortical loop, and this effect is exacerbated by the clinical efficacy of DBS parameters. Such data provides novel mechanistic and clinical insight, which may prove useful for characterizing DBS programming strategies to optimize motor symptom improvement in the future.

neurosciences

What problem does this paper attempt to address?

The paper primarily explores the mechanisms of Deep Brain Stimulation (DBS) in the treatment of Parkinson's disease, particularly focusing on DBS therapy targeting the subthalamic nucleus (STN). The main objective of the study is to understand how different DBS parameters (such as the directionality and intensity of the current) affect clinical efficacy and to explore the specific impacts of these parameters on brain activity and patients' motor functions.

Specifically, the paper attempts to address the following points:

1. **Impact of DBS Parameters**: The study evaluates how different DBS parameter settings (including optimal and suboptimal contact points and varying current intensities) affect the electrophysiological responses of the patients' brains and their motor performance.

2. **Neurophysiological Biomarkers**: The paper utilizes magnetoencephalography (MEG) technology to detect electrophysiological changes in the cerebral cortex, particularly in motor-related areas such as the primary sensorimotor cortex (SM1), supplementary motor area (SMA), and middle frontal gyrus (MFG).

3. **Behavioral Indicators**: The paper assesses the impact of DBS on motor function by quantifying performance in finger-tapping tasks and analyzing the relationship between these behavioral data and brain electrophysiological activity.

4. **Mechanism Exploration**: The study hypothesizes that DBS improves patients' motor symptoms by activating the hyperdirect pathway (HDP) to inhibit cortical beta synchrony. The paper further explores whether this mechanism depends on the choice of DBS parameters.

In summary, this paper aims to reveal the biological basis of optimal parameter settings in DBS therapy through a comprehensive analysis of neurophysiological and behavioral data, providing scientific evidence for optimizing DBS treatment strategies for Parkinson's disease patients.